American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 349-353 , September 2007

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: An Overview

  • Daniel E. Weiner, MD, MS

      Affiliations

    • Corresponding Author InformationAddress correspondence to Daniel E. Weiner, MD, MS, Division of Nephrology, Tufts-New England Medical Center Box #391, 750 Washington St, Boston, MA 02111.
    • ,
  • Andrew S. Levey, MD

  • Image Result

    Epoetin dose by facility status and chain. (A) The adjusted mean weekly epoetin dose in December 2004. (B) The adjusted change in epoetin dose between November and December 2004. Chains 1, 2, 3, 4, an

    Epoetin dose by facility status and chain. (A) The adjusted mean weekly epoetin dose in December 2004. (B) The adjusted change in epoetin dose between November and December 2004. Chains 1, 2, 3, 4, and 6 are for-profit. Error bars indicate 95% confidence intervals. Depicted patients are the subpopulation of white men residing in the Southeast, aged greater than or equal to 65 years, with diabetes, cardiovascular disease, and other comorbid conditions. Reprinted with permission from Thamer et al.1

PII: S0272-6386(07)01033-5

doi: 10.1053/j.ajkd.2007.07.003

American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 349-353 , September 2007

Article Tools

* Image Usage & Resolution